Sign in
WithdrawnPhase 4

Comparing Diuretic Strategies in Hospitalized Heart Failure

Key facts

Who runs it
Stanford University
Where
Palo Alto, United StatesSee the site
Trial code
Status
Withdrawn
Phase
Phase 4
Started
Jul 2023
Ended
Jun 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Loop Diuretics vs. loop + thiazide diuretics
Record updated
12 April 2023
Why it stopped
Due to administrative and logistical barriers this trial has been withdrawn.

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Any adult (age ≥18 years) admitted to the Heart Failure Service at Stanford Health Care with an indication for treatment with a diuretic

Who cannot take part

  • admission to the intensive care unit or cardiac care units
  • history of heart transplant
  • allergy / intolerance to loop or thiazide diuretics
  • admission serum sodium < 125 meq/L (from EPIC)
  • admission serum potassium < 3.0 meq/L (from EPIC)
  • maintenance dialysis on admission
  • any mechanical circulatory support on admission

Where in United States

  • Stanford Health CarePalo Alto, United States

About the trial

What the trial wants to find out

We will conduct a pragmatic randomized trial comparing whether using a combination of two types of diuretics (loop + thiazide) compared with using a single diuretic (loop only) will result in shorter hospital stays for patients hospitalized with heart failure.

The 2 groups in the trial

  • Loop onlyExisting treatment, for comparison

    Participants will receive a loop diuretic for up to the first 72 hours of hospitalization. The specific drug, dose and route are left to the treating providers.

    Treatment: Loop Diuretics vs. loop + thiazide diuretics

  • Loop + ThiazideExisting treatment, for comparison

    Participants will receive a loop+thiazide diuretic for up to the first 72 hours of hospitalization. The specific drugs, doses and routes are left to the treating providers.

    Treatment: Loop Diuretics vs. loop + thiazide diuretics

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Creating a Platform for Point-of-Care Pragmatic Clinical Trials: Comparing Diuretic Strategies in Heart Failure
Record updated
12 April 2023